Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124220893 | 12422089 | 3 | F | 20160111 | 20160924 | 20160531 | 20160926 | EXP | US-ROCHE-1713103 | ROCHE | 79.10 | YR | F | Y | 46.50000 | KG | 20160926 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124220893 | 12422089 | 1 | PS | Atezolizumab | ATEZOLIZUMAB | 1 | Intravenous (not otherwise specified) | MOST RECENT DOSE OF ATEZOLIZUMAB PRIOR TO DECREASED WBC, ELEVATED AST AND ELEVATED ALT ONSET WAS 120 | 1149441 | 761034 | 1200 | MG | Q3W | ||||||
| 124220893 | 12422089 | 2 | SS | NAB-Paclitaxel | PACLITAXEL | 1 | Intravenous (not otherwise specified) | MOST RECENT DOSES OF NAB-PACLITAXEL PRIOR TO ELEVATED ALT, ELEVATED AST ONSET WAS 139 MG ON 19/JAN/2 | 1148942,6109431 | 0 | 100 | MG/M**2 | /wk | ||||||
| 124220893 | 12422089 | 3 | SS | CARBOPLATIN. | CARBOPLATIN | 1 | Intravenous (not otherwise specified) | MOST RECENT DOSE OF CARBOPLATIN PRIOR TO DECREASED WBC, ELEVATED ALT AND ELEVATED AST WAS ON 05/JAN | 0 | 6 | MG/M**2 | Q3W | |||||||
| 124220893 | 12422089 | 4 | C | FOSAMAX | ALENDRONATE SODIUM | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124220893 | 12422089 | 1 | Non-small cell lung cancer |
| 124220893 | 12422089 | 2 | Non-small cell lung cancer |
| 124220893 | 12422089 | 3 | Non-small cell lung cancer |
| 124220893 | 12422089 | 4 | Osteoporosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124220893 | 12422089 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124220893 | 12422089 | Alanine aminotransferase increased | |
| 124220893 | 12422089 | Aspartate aminotransferase increased | |
| 124220893 | 12422089 | Blood alkaline phosphatase increased | |
| 124220893 | 12422089 | Neutrophil count decreased | |
| 124220893 | 12422089 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124220893 | 12422089 | 1 | 20160105 | 0 | ||
| 124220893 | 12422089 | 2 | 20160105 | 0 | ||
| 124220893 | 12422089 | 3 | 20160105 | 0 | ||
| 124220893 | 12422089 | 4 | 20130522 | 0 |